Inhibikase Therapeutics Balance Sheet (2020-2025) | IKT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Assets
Current Assets
Cash & Equivalents	0.01M	0.01M	0.02M	13.95M	9.61M	46.84M	44.85M	40.75M	36.61M	32.21M	5.78M	7.19M	3.96M	1.91M	14.86M	9.17M	2.35M	3.09M	0.91M	56.49M	73.44M	77.74M	38.27M
Short-term Investments											20.75M	15.86M	21.76M	19.03M	1.97M	4.09M	7.40M	4.85M	2.33M	41.05M	19.74M	9.92M	39.05M
Cash & Current Investments	0.01M	0.01M	0.02M	13.95M	9.61M	46.84M	44.85M	40.75M	36.61M	32.21M	26.53M	23.05M	25.72M	20.94M	16.83M	13.25M	9.75M	7.94M	3.24M	97.54M	93.18M	87.67M	77.32M
Receivables - Net								0.11M	0.05M	0.01M	0.01M	0.04M	0.06M	0.08M
Receivables - Other					0.33M	0.59M	0.22M
Receivables								0.11M	0.05M	0.01M	0.01M	0.04M	0.06M	0.08M
Prepaid Assets				0.77M	1.22M	0.96M	0.54M	1.50M	1.17M	0.92M	0.93M	1.12M	0.92M	0.54M	0.37M	0.74M	0.85M	0.36M	0.28M	0.83M	0.93M	0.68M	0.62M
Current Assets				14.78M	11.87M			42.47M		33.95M	27.99M	24.37M	27.63M	21.98M	17.55M	14.21M	10.81M	8.60M	4.19M	98.45M	94.16M	88.79M	78.54M
Non-Current Assets
Property, Plant & Equipment (Net)										0.04M	0.24M	0.24M	0.23M	0.09M	0.08M	0.07M	0.07M	0.06M	0.05M	0.05M	0.05M	0.02M
Other Non-Current Assets					0.00M																		1.00M
Non-Current Assets					0.00M					0.04M	0.59M	0.57M	0.53M	0.36M	0.33M	0.30M	0.26M	0.22M	0.19M	0.15M	0.12M	0.06M	1.06M
Assets				14.78M	11.87M	49.22M	45.87M	42.47M	38.39M	33.99M	28.58M	24.94M	28.16M	22.35M	17.88M	14.51M	11.07M	8.83M	4.38M	98.60M	94.28M	88.85M	79.59M
Liabilities
Current Liabilities
Accounts Payables				1.72M	1.34M	1.77M	2.46M	1.09M	4.38M	4.49M	20.75M	1.15M	21.76M	19.03M	1.97M	0.65M	3.80M	3.38M	2.53M	0.94M	1.69M	2.70M	0.62M
Notes Payables				0.32M	1.24M	0.25M	0.25M	0.25M
Payables				2.04M	2.59M	2.02M	2.71M	1.34M	4.38M	4.49M	20.75M	1.15M	21.76M	19.03M	1.97M	0.65M	3.80M	3.38M	2.53M	0.94M	1.69M	2.70M	0.62M
Accumulated Expenses				0.63M	0.63M	0.87M	1.91M	2.72M	3.57M	3.63M	2.29M	2.40M	1.56M	1.83M	1.86M	2.26M	2.51M	2.03M	2.16M	2.68M	3.51M	3.15M	3.66M
Other Accumulated Expenses				0.05M	0.00M	0.01M	0.01M	0.01M	0.02M	0.01M	3.07M	0.01M	2.66M	2.73M	2.74M	0.10M	0.03M	0.01M	0.01M	0.08M	0.13M	0.07M	0.12M
Short term Debt											0.14M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.11M	0.07M	0.04M
Current Deferred Revenue				2.33M	1.25M	0.14M				0.02M	0.02M
Total Current Liabilities				4.72M	3.59M	1.91M	2.71M	4.05M			3.21M	3.70M	2.66M	2.73M	2.74M	3.44M	4.23M	3.70M	4.91M	3.73M	8.55M	8.80M	6.70M
Non-Current Liabilities
Capital Leases											0.23M	0.21M	0.18M	0.15M	0.12M	0.09M	0.06M
Non-Current Debt				0.28M	0.25M	0.25M
Total Liabilities				5.00M	3.84M	2.16M	2.71M	4.05M	4.38M	4.49M	3.45M	3.90M	2.84M	2.88M	2.86M	3.53M	4.29M	3.73M	4.91M	3.73M	8.55M	8.80M	6.70M
Shareholder's Equity
Total Debt				0.28M	0.25M	0.25M					0.14M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.11M	0.07M	0.04M
Common Equity	-4.70M	-4.83M	-5.13M	9.78M	8.04M	47.05M	43.16M	38.42M	34.01M	29.50M	25.14M	21.04M	25.28M	19.46M	15.02M	10.98M	6.78M	5.10M	-0.53M	94.87M	85.73M	80.05M	72.90M
Shareholder's Equity	-4.70M	-4.83M	-5.13M	9.78M	8.04M	47.05M	43.16M	38.42M	34.01M	29.50M	25.14M	21.04M	25.28M	19.46M	15.02M	10.98M	6.78M	5.10M	-0.53M	94.87M	85.73M	80.05M	72.90M
Liabilities and Shareholders Equity				14.78M	11.87M	49.22M	45.87M	42.47M	38.39M	33.99M	28.58M	24.94M	28.16M	22.35M	17.88M	14.51M	11.07M	8.83M	4.38M	98.60M	94.28M	88.85M	79.59M
Retained Earnings				15.03M	-17.67M	-20.30M	-24.78M	-29.82M	-34.46M	-39.10M	-43.59M	-47.87M	-52.35M	-58.13M	-62.72M	-66.90M	-71.55M	-76.51M	-82.29M	-94.42M	-108.10M	-118.01M	-129.95M

Research Tools

Inhibikase Therapeutics Balance Sheet (2020-2025) | IKT

Create an account

Sign In

Reset Password

Get Pro for 60% off